Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

firstwordpharma.com
firstwordpharma.com > story > 7973027

Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more

2+ day, 19+ hour ago   (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7972962

AbbVie aims to expand Qulipta's label into new migraine market

2+ day, 20+ hour ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7969518

NodThera rebrands as Rezera, charts registrational path for PAD drug

3+ day, 13+ hour ago   (12+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7968650

Encoded pulls in $275M for pivotal study of Dravet gene therapy

3+ day, 21+ hour ago   (13+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7967524

TwoStep's take on targeting solid tumours gains backing from Merck KGaA, Pfizer venture arms

4+ day, 3+ hour ago   (16+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7967798

Beeline buzzes ahead to pivotal lupus trials after mid-stage success

4+ day, 2+ hour ago   (12+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7961783

Amgen claims win for Imdelltra in maintenance lung cancer setting

5+ day, 1+ hour ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7960102

Roivant's pulmonary hypertension drug mosliciguat scores mid-stage win

5+ day, 9+ hour ago   (10+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7959810

Novartis??? Avidity-sourced del-desiran stumbles in Phase III myotonic dystrophy study

5+ day, 12+ hour ago   (12+ words) Novartis’ Avidity-sourced del-desiran stumbles in Phase III myotonic dystrophy study FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7958314

Vital Signs: Who's enjoying the fruits of pharma's labor?

6+ day, 2+ hour ago   (10+ words) firstwordpharma.com...